TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Tarpoon Bioscience AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
565
|
915
|
1,004 |
Financial expenses |
0
![]() |
0
|
97 |
Earnings before taxes |
345
|
168
|
112 |
EBITDA |
324
|
160
|
209 |
Total assets |
2,216
|
2,105
|
2,165 |
Current assets |
752
|
649
|
670 |
Current liabilities |
64
|
159
|
143 |
Equity capital |
2,039
|
1,850
|
1,914 |
- share capital |
67
![]() |
67
|
73 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
92.0%
|
87.9%
|
88.4% |
Turnover per employee |
565
|
915
|
1,004 |
Profit as a percentage of turnover |
61.1%
|
18.4%
|
11.2% |
Return on assets (ROA) |
15.6%
|
8.0%
|
9.7% |
Current ratio |
1175.0%
|
408.2%
|
468.5% |
Return on equity (ROE) |
16.9%
|
9.1%
|
5.9% |
Change turnover |
-355
|
-8
|
23 |
Change turnover % |
-39%
|
-1%
|
2% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.